-+ 0.00%
-+ 0.00%
-+ 0.00%

ENTRADA THERAPEUTICS SHARES SLUMP 61% TO $6.05 AFTER CO'S DUCHENNE DRUG MISSES EXPECTATIONS IN TRIAL

Reuters·05/07/2026 13:38:30

Please log in to view news